Vaccines for seasonal and pandemic influenza

Keyphrases

• Age Groups 33%
• Age Spectrum 33%
• All Ages 33%
• Alum 33%
• Cold-adapted 33%
• Commercially Available 33%
• Cost Savings 33%
• Excess Mortality 33%
• Existing Technology 33%
• Generation Approach 33%
• Health Benefits 33%
• Hospitalization 33%
• Illness 33%
• Immune Response 33%
• Immunogenic 33%
• Inactivated Vaccine 66%
• Influenza 33%
• Influenza Prevention 66%
• Influenza Vaccine 33%
• Influenza Vaccine Effectiveness 33%
• Live Attenuated Influenza Vaccine 33%
• Live Attenuated Vaccine 33%
• MF59 33%
• Pandemic Influenza Virus 100%
• Pandemic Outbreak 33%
• Pandemic Strains 33%
• Pandemic Vaccine 33%
• Routine Vaccination 33%
• Seasonal Influenza 100%
• State Accounting 33%
• Trivalent Inactivated Influenza Vaccine 33%
• United States 66%
• Vaccination 100%
• Vaccination Rate 33%
• Vaccine Delivery 33%
• Vaccine Development 33%
• Vaccine Supply 33%

Medicine and Dentistry

• Adjuvant 25%
• Diseases 25%
• Health Care Cost 50%
• Immune Response 25%
• Inactivated Vaccine 50%
• Influenza Vaccine 100%
• Live Vaccine 25%
• Low Drug Dose 25%
• Mifamurtide 25%
• Pandemic Influenza 100%
• Seasonal Influenza 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Adjuvant 25%
• Diseases 25%
• Inactivated Vaccine 50%
• Live Attenuated Influenza Vaccine 100%
• Live Vaccine 25%
• MF59 25%
• Pandemic Influenza 100%
• Seasonal Influenza 100%